NIH-funded research Sbir 1 grant

Improving medication management to reduce dementia risk in African Americans and Latinos

Official title: Enhanced Medication Management to Control ADRD Risk Factors Among African Americans and Latinos

Funded at Pilltrax Systems LLC · NIH-10610975 · Data updated 2026-11-12

This study is all about helping African Americans and Latinos take their medications regularly to better manage conditions like high blood pressure and diabetes, which can lower the risk of developing Alzheimer's disease and related dementias, using tools like a smart pill dispenser and text reminders.

More Risk Factors research and trials

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionPilltrax Systems LLC
NIH-funded
Lab location1 site (Brighton, UNITED STATES)
Project startSeptember 18, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$299,553
NIH project number1R43AG081035-01
Project IDNIH-10610975 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are African American and Latino individuals who are at risk for Alzheimer's disease and related dementias due to hypertension or diabetes.

Less likely to help

Patients who do not have hypertension or diabetes, or those who are not part of the African American or Latino communities may not benefit from this research.

What this research studies

This research focuses on enhancing medication adherence among African Americans and Latinos to better manage risk factors for Alzheimer's disease and related dementias (ADRD). It aims to implement a medication management service that includes an electronic pill dispenser, SMS notifications for medication adherence, and a provider portal for tracking adherence data. By addressing the low adherence rates to hypertension and diabetes medications, the project seeks to lower the risk of developing ADRD in these populations. The approach is designed to be proactive and supportive, helping patients stay on track with their medications.

Why it matters

Potential benefit: If successful, this research could significantly reduce the risk of Alzheimer's disease and related dementias among African Americans and Latinos.

How similar studies have gone: Previous research has shown that improving medication adherence can lead to better health outcomes, indicating that this approach has potential for success.

Where this research is happening

  • Pilltrax Systems LLC
    Brighton, United States
    Active

Researchers

  • Principal investigator: Ramsey, Alvin — Pilltrax Systems LLC
  • Study coordinator: Ramsey, Alvin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.